These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 8482854)

  • 1. A conserved 3D pattern in a Streptococcus pyogenes M protein immunogen elicits M-type crossreactivity.
    Wang KC; Kuliyev E; Nizet V; Ghosh P
    J Biol Chem; 2023 Aug; 299(8):104980. PubMed ID: 37390991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an experimental model to determine streptococcal M protein-induced autoimmune cardiac and neurobehavioral abnormalities.
    Rafeek RA; Hamlin AS; Andronicos NM; Lawlor CS; McMillan DJ; Sriprakash KS; Ketheesan N
    Immunol Cell Biol; 2022 Sep; 100(8):653-666. PubMed ID: 35792671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus pyogenes genes that promote pharyngitis in primates.
    Zhu L; Olsen RJ; Beres SB; Saavedra MO; Kubiak SL; Cantu CC; Jenkins L; Waller AS; Sun Z; Palzkill T; Porter AR; DeLeo FR; Musser JM
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32493846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge issues in rheumatic fever.
    Chang C
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):213-37. PubMed ID: 21597903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of rheumatic heart disease in the developing world.
    Steer AC; Carapetis JR
    Nat Rev Cardiol; 2009 Nov; 6(11):689-98. PubMed ID: 19752868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.
    Carvalho-Queiroz C; Cook R; Wang CC; Correa-Oliveira R; Bailey NA; Egilmez NK; Mathiowitz E; LoVerde PT
    Infect Immun; 2004 May; 72(5):2635-47. PubMed ID: 15102772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concept of pathophysiological understanding and natural course of ulcerative colitis.
    Holtmann MH; Galle PR
    Langenbecks Arch Surg; 2004 Oct; 389(5):341-9. PubMed ID: 14760536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study.
    Jones KF; Whitehead SS; Cunningham MW; Fischetti VA
    Infect Immun; 2000 Dec; 68(12):7132-6. PubMed ID: 11083840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.
    Brandt ER; Teh T; Relf WA; Hobb RI; Good MF
    Infect Immun; 2000 Dec; 68(12):6587-94. PubMed ID: 11083769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine strategies to prevent rheumatic fever.
    Brandt ER; Good MF
    Immunol Res; 1999; 19(1):89-103. PubMed ID: 10374697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological relationship between the class I epitope of streptococcal M protein and myosin.
    Quinn A; Ward K; Fischetti VA; Hemric M; Cunningham MW
    Infect Immun; 1998 Sep; 66(9):4418-24. PubMed ID: 9712796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein.
    Cunningham MW; Antone SM; Smart M; Liu R; Kosanke S
    Infect Immun; 1997 Sep; 65(9):3913-23. PubMed ID: 9284171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.
    Liao L; Sindhwani R; Rojkind M; Factor S; Leinwand L; Diamond B
    J Exp Med; 1995 Mar; 181(3):1123-31. PubMed ID: 7869033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
    Vashishtha A; Fischetti VA
    J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the immunodeterminants of the complete streptococcal M6 protein molecule. Identification of an immunodominant region.
    Fischetti VA; Windels M
    J Immunol; 1988 Nov; 141(10):3592-9. PubMed ID: 2460540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
    Beachey EH; Seyer JM
    J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin?
    Valdimarsson H; Sigmundsdóttir H; Jónsdóttir I
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():21-4. PubMed ID: 9020931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective and autoimmune epitopes of streptococcal M proteins.
    Beachey EH; Bronze M; Dale JB; Kraus W; Poirier T; Sargent S
    Vaccine; 1988 Apr; 6(2):192-6. PubMed ID: 3291457
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.